Docetaxel
Who holds supplier records for Docetaxel? 25 organisations hold a current record for Docetaxel: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (7), India (7), Canada (2), Taiwan (1) and 4 other countries (4); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Docetaxel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/docetaxel
Reading the evidence
- 25 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Docetaxel expires 16 May 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (25)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Docetaxel. Country is the organisation's recorded country, not necessarily the manufacturing site.
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 20942, 20021, 30091 · latest filing Jan 2016
- INDENA SPAItalyCEP Company GMP cert on recordActive DMF 23886, 33209 · latest filing Sept 2018
- Chongqing Sintaho Pharmaceutical Co., Ltd.ChinaCEPActive DMF 37224 · latest filing Jun 2022
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 27457 · latest filing Aug 2013
- Qilu Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 23458, 25576 · latest filing Dec 2011
- WUHAN CALMLAND PHARMACEUTICALS CO LTDChinaCEP Company GMP cert on recordActive DMF 36878 · latest filing Mar 2022
- BIOVECTRA INCCanadaActive DMF 21517 · latest filing Apr 2008
- CENWAY PHARMACEUTICALS CO LTDActive DMF 23406 · latest filing Dec 2009
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 27771, 25804 · latest filing Jan 2014
- HAINAN YEW PHARMACEUTICAL CO LTDActive DMF 31071 · latest filing Oct 2016
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina Company GMP cert on recordActive DMF 24175 · latest filing Sept 2010
- TAPI NL BVNetherlandsActive DMF 23054 · latest filing Aug 2009
- YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDActive DMF 26652 · latest filing Dec 2012
- IndiaCEP Company GMP cert on record
- FRESENIUS KABI ONCOLOGY LTDIndiaCEP Company GMP cert on recordInactive DMF 25103 · latest filing Jul 2011
- Fujian South Pharmaceutical Co. Ltd.ChinaCEP
- IndiaCEP Company GMP cert on record
- Hubei Haosun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- POLYMED THERAPEUTICS INCCEPInactive DMF 21040 · latest filing Nov 2007
- SAMYANG HOLDINGS CORPSouth KoreaCEPInactive DMF 25678 · latest filing Jan 2012
- FranceCEP Company GMP cert on record
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- PHYTON BIOTECH LLCCanadaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (18)
Certificates of Suitability on the EDQM register for Docetaxel, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 32 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou | CN | CEP 2021-302 - Rev 01 Docetaxel, Process II | Nov 2026 | Inspected Aug 2024 Belgium |
| WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan | CN | CEP 2022-011 - Rev 01 Docetaxel | Jan 2026 | Inspected Apr 2026 Croatia |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2022-149 - Rev 02 Docetaxel trihydrate | Oct 2025 | — |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan | CN | CEP 2025-133 - Rev 00 Docetaxel trihydrate, Shandong Anxin site | Sept 2025 | Inspected Sept 2023 Austria, outside 3-year window |
| FUJIAN SOUTH PHARMACEUTICAL CO., LTD. Sanming | CN | CEP 2016-204 - Rev 05 Docetaxel | Jul 2025 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2020-155 - Rev 02 Docetaxel, Process-IIb | Jul 2025 | — |
| CHONGQING SINTAHO PHARMACEUTICAL CO., LTD. Maliuzui | CN | CEP 2022-295 - Rev 01 Docetaxel | May 2025 | — |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2012-287 - Rev 02 Docetaxel, Process-2 | Feb 2025 | — |
| FRESENIUS KABI ONCOLOGY LIMITED Kalyani | IN | CEP 2011-189 - Rev 05 Docetaxel trihydrate | Jan 2025 | — |
| QILU PHARMACEUTICAL CO., LTD. Jinan | CN | CEP 2014-105 - Rev 04 Docetaxel | Nov 2024 | Inspected Feb 2025 Switzerland |
| INDENA S.P.A. Milano | IT | CEP 2018-094 - Rev 02 Docetaxel trihydrate | Oct 2024 | Inspected Jun 2026 Italy |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | CEP 2016-339 - Rev 01 Docetaxel, Code SPT1298 | Sept 2024 | — |
| SANOFI WINTHROP INDUSTRIE Gentilly | FR | CEP 2009-343 - Rev 04 Docetaxel trihydrate | Mar 2024 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | R1-CEP 2015-336 - Rev 01 Docetaxel | Aug 2023 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2013-109 - Rev 01 Docetaxel | Jul 2022 | — |
| SAMYANG HOLDINGS CORPORATION Gyeonggi-do | KR | R1-CEP 2013-185 - Rev 01 Docetaxel | Aug 2021 | — |
| PHYTON BIOTECH LLC Delta | CA | R1-CEP 2012-105 - Rev 01 Docetaxel | Oct 2019 | — |
| POLYMED THERAPEUTICS, INC. Houston | US | R1-CEP 2012-029 - Rev 01 Docetaxel | Mar 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Docetaxel are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- China · Inactive DMF 27433 · filed Sept 2013
- MAC CHEM PRODUCTS INDIA PVT LTDInactive DMF 26580 · filed Oct 2012
- Sichuan Xieli Pharmaceutical Co LtdChina · Inactive DMF 26328 · filed Aug 2012
- India · Inactive DMF 25143 · filed Sept 2011
- Inactive DMF 21930 · filed Oct 2008
- SAI PHYTOCEUTICALS PVT LTDInactive DMF 20722 · filed Jun 2007
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (54 listed products contain Docetaxel). The latest listed patent expires 16 May 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Docetaxel is a chemotherapy medication that works by interfering with cell division, used primarily in the treatment of breast, lung, prostate, and other cancers. It is a semi-synthetic analogue of paclitaxel and functions as a microtubule inhibitor.
Chemical identity
- IUPAC name
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;trihydrate
- Canonical SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O.O.O.O
- InChIKey
- XCDIRYDKECHIPE-QHEQPUDQSA-N
- Synonyms
- Taxotere API, docetaxel (as trihydrate), docetaxel hydrate, docetaxel trihydrate, rp 56976, rp-56976, taxotere, xrp6976
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Microtubule Inhibitor
- Physiologic effect
- Microtubule Inhibition
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Docetaxel?
25 organisations hold an active US FDA Type II Drug Master File or a CEP for Docetaxel: SCINOPHARM TAIWAN LTD (Taiwan), INDENA SPA (Italy), Chongqing Sintaho Pharmaceutical Co., Ltd. (China), MSN Laboratories Private Limited (India), Qilu Pharmaceutical Co., Ltd. (China), WUHAN CALMLAND PHARMACEUTICALS CO LTD (China), BIOVECTRA INC (Canada) and CENWAY PHARMACEUTICALS CO LTD, and 17 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Docetaxel Drug Master Files are active?
SCINOPHARM TAIWAN LTD (DMF 20942, 20021), INDENA SPA (DMF 23886, 33209), Chongqing Sintaho Pharmaceutical Co., Ltd. (DMF 37224), MSN Laboratories Private Limited (DMF 27457), Qilu Pharmaceutical Co., Ltd. (DMF 23458, 25576), WUHAN CALMLAND PHARMACEUTICALS CO LTD (DMF 36878), BIOVECTRA INC (DMF 21517) and CENWAY PHARMACEUTICALS CO LTD (DMF 23406) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Docetaxel records mean?
6 organisations have only inactive Type II DMFs for Docetaxel. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Docetaxel have a European Certificate of Suitability?
Yes. 18 organisations hold a valid CEP for Docetaxel on the EDQM register, including HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou (CN), WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan (CN), HETERO LABS LIMITED Hyderabad (IN), SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan (CN), FUJIAN SOUTH PHARMACEUTICAL CO., LTD. Sanming (CN) and INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Docetaxel?
Yes. The latest patent listed for an approved US product containing Docetaxel expires 16 May 2036, across 54 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Docetaxel supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Docetaxel?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.